Tacrolimus active in refractory IBD Gastroenterology Update Oral tacrolimus could be a worthwhile option for patients with hard-to-treat inflammatory bowel disease, say Australian researchers. The drug induced a long-term clinical response in a third and remission in a fifth of cases in a study of 35 patients ... |
